Respiratory Subsets in Patients with Moderate to Severe Acute Respiratory Distress Syndrome for Early Prediction of

Jesús Villar1,2,3, Cristina Fernández2, Jesús M González-Martín1,2

  • 1CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Insights

A 24-hour PaO2/FiO2 ratio threshold of 150 mm Hg in acute respiratory distress syndrome (ARDS) patients predicts intensive care unit (ICU) mortality. This ARDS classification improves prognostication and aids in selecting therapies and trial enrollment.

Area of Science:

  • Critical Care Medicine
  • Pulmonary Medicine
  • Respiratory Physiology

Background:

  • The PaO2/FiO2 ratio at acute respiratory distress syndrome (ARDS) diagnosis has limited predictive value for mortality.
  • Lung-protective ventilation strategies are standard for ARDS management.
  • Accurate prognostication is crucial for guiding treatment intensity and clinical trial enrollment in ARDS.

Purpose of the Study:

  • To evaluate the hypothesis that a PaO2/FiO2 ratio threshold of 150 mm Hg at 24 hours post-ARDS diagnosis improves prediction of intensive care unit (ICU) mortality.
  • To assess the clinical relevance of patient subsets defined by PaO2/FiO2 and positive end-expiratory pressure (PEEP) levels for prognostication.

Main Methods:

  • An ancillary study involving 1303 patients with moderate to severe ARDS managed with lung-protective ventilation across four prospective multicenter cohorts.
  • Patients were classified into four subsets based on PaO2/FiO2 (150 mm Hg) and PEEP (10 cm H2O) thresholds at baseline and 24 hours.
  • Two cohorts were pooled as a testing set (n=1000) and one as a confirmatory set (n=303).

Main Results:

  • ICU mortality rates were similar between the testing (37.5%) and confirmatory (37.0%) cohorts.
  • At baseline, PaO2/FiO2 < 150 mm Hg was common (79.2%), with no significant mortality difference among subsets (p=0.23).
  • At 24 hours, ICU mortality significantly increased across subsets defined by PaO2/FiO2 and PEEP (p < 0.0001), with findings replicated in the confirmatory cohort.
  • Patients with PaO2/FiO2 < 150 mm Hg at 24 hours had significantly worse 30-day ICU survival (Hazard Ratio 2.8, p < 0.0001), independent of PEEP levels.

Conclusions:

  • Patient subsets defined by a 24-hour PaO2/FiO2 threshold of 150 mm Hg are clinically relevant for predicting ICU mortality in moderate/severe ARDS.
  • This classification aids in identifying patients who may benefit from adjunctive therapies for hypoxemia.
  • The 24-hour PaO2/FiO2 threshold is valuable for patient selection in therapeutic trials for ARDS.

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
192
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
183
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
319
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
287
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
273
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.2K